• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Dasatinib induced pleural effusions - Reply.

作者信息

Aj Abdulla Mohammad, Yassin Mohamed A

机构信息

.

Hematology Section, National Center for Cancer Care and Research, Hamad Medical Corporation, (HMC), Doha, Qatar.

出版信息

Acta Biomed. 2020 Mar 19;91(1):144-145. doi: 10.23750/abm.v91i1.9263.

DOI:10.23750/abm.v91i1.9263
PMID:32191671
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7569587/
Abstract
摘要

相似文献

1
Dasatinib induced pleural effusions - Reply.达沙替尼引起的胸腔积液——回复
Acta Biomed. 2020 Mar 19;91(1):144-145. doi: 10.23750/abm.v91i1.9263.
2
Pleural effusion in patients with chronic myelogenous leukemia treated with dasatinib after imatinib failure.伊马替尼治疗失败后使用达沙替尼治疗的慢性髓性白血病患者的胸腔积液
J Clin Oncol. 2007 Sep 1;25(25):3908-14. doi: 10.1200/JCO.2007.12.0329.
3
Incidence, risk factors and management of pleural effusions during dasatinib treatment in unselected elderly patients with chronic myelogenous leukaemia.未选择的老年慢性髓性白血病患者在接受达沙替尼治疗期间胸腔积液的发生率、风险因素和处理。
Hematol Oncol. 2013 Jun;31(2):103-9. doi: 10.1002/hon.2020. Epub 2012 Jul 19.
4
Dasatinib-induced pleural effusions: a lymphatic network disorder?达沙替尼诱导的胸腔积液：一种淋巴管网络紊乱？
Am J Med Sci. 2009 Nov;338(5):414-7. doi: 10.1097/MAJ.0b013e3181ae9227.
5
Pleural effusions due to dasatinib.达沙替尼引起的胸腔积液。
Curr Opin Pulm Med. 2010 Jul;16(4):351-6. doi: 10.1097/MCP.0b013e328338c486.
6
Pleural Effusion in Dasatinib-Treated Patients With Chronic Myeloid Leukemia in Chronic Phase: Identification and Management.达沙替尼治疗的慢性期慢性髓性白血病患者的胸腔积液：识别与管理
Clin Lymphoma Myeloma Leuk. 2017 Feb;17(2):78-82. doi: 10.1016/j.clml.2016.09.012. Epub 2016 Sep 17.
7
Pleural/pericardic effusions during dasatinib treatment: incidence, management and risk factors associated to their development.达沙替尼治疗期间的胸腔/心包积液：发生率、处理方法以及与积液发生相关的风险因素。
Expert Opin Drug Saf. 2010 Sep;9(5):713-21. doi: 10.1517/14740331003742935.
8
[A case report of refractory pleural effusion associated with dasatinib in the treatment of chronic myeloied leukemia].
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2015 Apr;23(2):401-6. doi: 10.7534/j.issn.1009-2137.2015.02.020.
9
Dasatinib induced pleuro-pericardial effusion.达沙替尼诱发了胸膜心包积液。
Acta Biomed. 2020 Mar 19;91(1):142-143. doi: 10.23750/abm.v91i1.8914.
10
[Efficacy of dasatinib in treatment of imatinib-resistant BCR/ABL positive leukemia].达沙替尼治疗伊马替尼耐药的BCR/ABL阳性白血病的疗效
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2013 Jun;21(3):581-6. doi: 10.7534/j.issn.1009-2137.2013.03.009.

本文引用的文献

1
An uncommon case of chronic myeloid leukemia with variant cytogenetic.一例罕见的伴有细胞遗传学变异的慢性髓性白血病。
Acta Biomed. 2018 Apr 3;89(3-S):28-32. doi: 10.23750/abm.v89i3-S.7217.
2
Incidence, risk factors and management of pleural effusions during dasatinib treatment in unselected elderly patients with chronic myelogenous leukaemia.未选择的老年慢性髓性白血病患者在接受达沙替尼治疗期间胸腔积液的发生率、风险因素和处理。
Hematol Oncol. 2013 Jun;31(2):103-9. doi: 10.1002/hon.2020. Epub 2012 Jul 19.
3
Pleural effusions due to dasatinib.达沙替尼引起的胸腔积液。
Curr Opin Pulm Med. 2010 Jul;16(4):351-6. doi: 10.1097/MCP.0b013e328338c486.
4
Dasatinib 100 mg once daily minimizes the occurrence of pleural effusion in patients with chronic myeloid leukemia in chronic phase and efficacy is unaffected in patients who develop pleural effusion.达沙替尼 100 毫克，每日一次，可最大程度减少慢性期慢性髓性白血病患者胸腔积液的发生，并且对发生胸腔积液的患者的疗效没有影响。
Cancer. 2010 Jan 15;116(2):377-86. doi: 10.1002/cncr.24734.
5
Dasatinib-induced pleural effusions: a lymphatic network disorder?达沙替尼诱导的胸腔积液：一种淋巴管网络紊乱？
Am J Med Sci. 2009 Nov;338(5):414-7. doi: 10.1097/MAJ.0b013e3181ae9227.
6
Dasatinib in chronic myelogenous leukemia.达沙替尼用于慢性粒细胞白血病
N Engl J Med. 2006 Sep 7;355(10):1062; author reply 1063-4. doi: 10.1056/NEJMc061882.